首页> 外国专利> METHOD FOR DIAGNOSTICS OF DEVELOPMENT OF DIABETIC CARDIOMYOPATHY IN PATIENTS WITH DIABETES INSULAR OF TYPE 2 WITH INCREASED BODY MASS AND OBESITY

METHOD FOR DIAGNOSTICS OF DEVELOPMENT OF DIABETIC CARDIOMYOPATHY IN PATIENTS WITH DIABETES INSULAR OF TYPE 2 WITH INCREASED BODY MASS AND OBESITY

机译:诊断为2型糖尿病,糖尿病和肥胖症患者的糖尿病性心肌病发展的诊断方法

摘要

A method for diagnostics of development of diabetic cardiomyopathy in patients with type 2 diabetes mellitus with increased body weight and obesity includes determination of the level of pro-inflammatory interleukins IL-6 and IL-1(. In patients with type 2 diabetes mellitus with increased body weight and obesity the level of those interleukins is determined in blood serum of patient with immunoenzyme method by means of kit of Vector-Best reagents, and diabetic cardiomyopathy is diagnosed in patients with increased body weight at level of IL-1( of 11.34±0.25 pg/ml, and IL-6 – 10.7±0.27 pg/ml; in patients with obesity diabetic cardiomyopathy is diagnosed at level of IL-1( 14.76±0.28 pg/ml and level of IL-6 – 13.28±0.27 pg/ml.
机译:诊断体重增加和肥胖的2型糖尿病患者糖尿病性心肌病发展的方法包括测定促炎性白介素IL-6和IL-1(。体重和肥胖症用Vector-Best试剂盒通过免疫酶方法测定患者血清中那些白细胞介素的水平,并且在体重增加至IL-1水平时诊断为糖尿病性心肌病(11.34± 0.25 pg / ml和IL-6 – 10.7±0.27 pg / ml;在肥胖型糖尿病性心肌病患者中,诊断为IL-1(14.76±0.28 pg / ml和IL-6 – 13.28±0.27 pg / ml毫升

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号